ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 225,44
0,46%
Dow Jones
39 507,29
0,30%
DAX
18 773,99
0,50%
Brent Oil
83,875
-0,09%
Bitcoin
62 891,48
-0,26%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Aston Martin Np (AMLN)

  7. Aston Martin Np (AMLN) Actualités

AMLN

Aston Martin Np (AMLN)

Aston Martin Np
De:
Trier par:
 Showing the most relevant articles for your search:LSE:AMLN
DateHeureSourceTitreSymboleSociété
26/09/202217h36UK RegulatoryAston Martin Lagonda Global - AMLN Price Monitoring ExtensionLSE:AMLNAston Martin Np
23/09/202217h41UK RegulatoryAston Martin Lagonda Global - AMLN Second Price Monitoring ExtnLSE:AMLNAston Martin Np
13/01/201015h31PR Newswire (US)Critical Alerts for Hartford Financial Services, Apple, Yamana Gold, Amylin Pharmaceuticals and MetLife Released by Seven SummitNASDAQ:AMLN
05/11/200922h15PR Newswire (US)Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare ConferenceNASDAQ:AMLN
02/11/200900h30PR Newswire (US)Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to Co-Develop and Commercialize Compounds for ObesityNASDAQ:AMLN
31/10/200901h16PR Newswire (US)BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 DiabetesNASDAQ:AMLN
29/10/200913h34Dow Jones NewsUPDATE: Roche's New Diabetes Drug Works Better Than ByettaNASDAQ:AMLNAmylin Pharmaceuticals Inc.
29/10/200910h02Dow Jones NewsRoche: New Diabetes Drug Works Better Than Byetta - StudyNASDAQ:AMLNAmylin Pharmaceuticals Inc.
22/10/200914h00PR Newswire (US)Amylin Pharmaceuticals to Present at the 4th Annual BIOCOM Investor ConferenceNASDAQ:AMLN
19/10/200923h21Dow Jones News2ND UPDATE:Galleon Holdings Include OSI Pharma,Huron ConsultingNASDAQ:AMLNAmylin Pharmaceuticals Inc.
19/10/200922h17Dow Jones NewsUPDATE: Galleon Holdings Include OSI Pharma, Huron ConsultingNASDAQ:AMLNAmylin Pharmaceuticals Inc.
19/10/200922h05Dow Jones NewsGalleon Holdings Include OSI Pharmaceuticals, Huron ConsultingNASDAQ:AMLNAmylin Pharmaceuticals Inc.
30/09/200912h16Dow Jones NewsNovo Nordisk's Diabetes Drug Victoza Successful In StudyNASDAQ:AMLNAmylin Pharmaceuticals Inc.
24/08/200913h45PR Newswire (US)Amylin Pharmaceuticals Board of Directors Elects Paulo F. Costa Chairman of the BoardNASDAQ:AMLN
06/08/200914h28Dow Jones NewsNovo Nordisk CEO: Positive Victoza Reception In EuropeNASDAQ:AMLNAmylin Pharmaceuticals Inc.
21/07/200923h20Dow Jones NewsAmylin 2Q Loss Narrows On Cost-Cutting; Byetta Sales SlipNASDAQ:AMLNAmylin Pharmaceuticals Inc.
20/07/200922h14PR Newswire (US)Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus(R) in Head-to-Head DURATION-3 StudyNASDAQ:AMLN
03/07/200913h01Dow Jones NewsUPDATE: Novo Nordisk Diabetes Drug Victoza Gets EU ApprovalNASDAQ:AMLNAmylin Pharmaceuticals Inc.
03/07/200912h06Dow Jones NewsNovo Nordisk's Victoza To Reach Market In A Few Weeks - CSONASDAQ:AMLNAmylin Pharmaceuticals Inc.
09/06/200912h30Dow Jones NewsDoctors Say New Diabetes Drugs Hold Great PromiseNASDAQ:AMLNAmylin Pharmaceuticals Inc.
09/06/200909h13Dow Jones NewsCORRECT: Study: Novo Nordisk's Diabetes Drug Beats Lilly's ByettaNASDAQ:AMLNAmylin Pharmaceuticals Inc.
09/06/200909h12Dow Jones NewsNovo Nordisk Diabetes Drug Liraglutide Successful In StudyNASDAQ:AMLNAmylin Pharmaceuticals Inc.
09/06/200909h12Dow Jones NewsStudy: Novo Nordisk's Diabetes Drug Beats Lilly's ByettaNASDAQ:AMLNAmylin Pharmaceuticals Inc.
07/06/200902h00Dow Jones NewsUPDATE: Weekly Diabetes Drug Byetta Outdoes CompetitorsNASDAQ:AMLNAmylin Pharmaceuticals Inc.
06/06/200921h22Dow Jones NewsStudy Shows Weekly Byetta Diabetes Drug Outdoes CompetitorsNASDAQ:AMLNAmylin Pharmaceuticals Inc.
02/06/200919h59Dow Jones NewsUPDATE: Amylin: 2 Dissidents To Replace Chairman, Lead DirNASDAQ:AMLNAmylin Pharmaceuticals Inc.
02/06/200919h36Dow Jones NewsAmylin: 2 Dissidents To Replace Chairman, Lead DirectorNASDAQ:AMLNAmylin Pharmaceuticals Inc.
27/05/200922h37Dow Jones NewsUPDATE: Amylin: Dissidents Likely Got Up To Two Board SeatsNASDAQ:AMLNAmylin Pharmaceuticals Inc.
27/05/200922h05Dow Jones NewsEastbourne Claims Success In Electing Directors To Amylin BoardNASDAQ:AMLNAmylin Pharmaceuticals Inc.
21/05/200921h02Dow Jones NewsHedge Fund Mgr Schoenfeld Backs Icahn/Eastbourne Amylin SlateNASDAQ:AMLNAmylin Pharmaceuticals Inc.
 Showing the most relevant articles for your search:LSE:AMLN

Dernières Valeurs Consultées

NYSE
DIS
Walt Disney
SPI
SP500
S&P 500
EU
SGO
Cie de SaintGobain
EU
HO
Thales
FTSE
UKX
FTSE 100
NYSE
NKE
Nike
EU
ACA
Credit Agricole
EU
CS
Axa
NYSE
MCD
McDonalds
EU
DG
Vinci
EU
CAP
Capgemini
EU
LR
Legrand
NASDAQ
GOOGL
Alphabet
NYSE
MRK
Merck
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés